Cytori Provides Latest Corporate Update at the 18th Annual B. Riley & Co. Institutional Investor Conference
May 16 2017 - 8:30AM
Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced today that it
will present at the 18th Annual B. Riley & Co.
Institutional Investor Conference at 09:00 AM Pacific Time (12 PM
Eastern Time) on Wednesday, May 24, 2017. The presentation will
take place in the Arcadia D room at the Lowes Santa Monica Beach
Hotel, in Santa Monica, CA. Dr. Marc Hedrick, CEO and President of
Cytori Therapeutics, will provide an update on current corporate
activities and recent developments.
Cytori management will be available for one-on-one meetings at
the conference. Attending investors who are interested in meeting
management are encouraged to contact their B. Riley representative
or Cytori (ir@cytori.com).
A live audio and video webcast of the presentation will be
available under the investor relations section of Cytori’s website
at www.cytori.com (http://ir.cytori.com). A replay of the
presentation will be available for 30 days following the event.
Please connect to Cytori’s website several minutes prior to the
start of the webcast to ensure adequate time for any software
download that may be necessary.
About Cytori Therapeutics
Cytori is a therapeutics company developing regenerative and
oncologic therapies from its proprietary cell therapy and
nanoparticle platforms for a variety of medical conditions. Data
from preclinical studies and clinical trials suggest that Cytori
Cell Therapy™ acts principally by improving blood flow, modulating
the immune system, and facilitating wound repair. As a result,
Cytori Cell Therapy™ may provide benefits across multiple disease
states and can be made available to the physician and patient at
the point-of-care through Cytori’s proprietary technologies and
products. Cytori Nanomedicine™ is developing encapsulated therapies
for regenerative medicine and oncologic indications. For more
information, visit www.cytori.com.
About B. Riley & Co., LLC B. Riley &
Co., LLC is a leading investment bank providing advisory, research,
and sales & trading to corporate, institutional and high net
worth individual clients. Investment banking services include
M&A advisory and debt and equity offerings. The firm is
nationally recognized for its highly ranked proprietary equity
research. B. Riley & Co. is a member of FINRA and SIPC. For
more information, please visit www.brileyco.com.
Cytori Therapeutics, Inc.
Tiago Girao, +1 (858) 458.0900
ir@cytori.com
Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart
From Apr 2023 to Apr 2024